CU23582A1 - Péptidos con capacidad anti-tumoral e inmunomoduladora - Google Patents
Péptidos con capacidad anti-tumoral e inmunomoduladoraInfo
- Publication number
- CU23582A1 CU23582A1 CU20060047A CU20060047A CU23582A1 CU 23582 A1 CU23582 A1 CU 23582A1 CU 20060047 A CU20060047 A CU 20060047A CU 20060047 A CU20060047 A CU 20060047A CU 23582 A1 CU23582 A1 CU 23582A1
- Authority
- CU
- Cuba
- Prior art keywords
- peptides
- immunomodulatory
- lipopolysaccharide
- well
- effect
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/43504—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates
- C07K14/43509—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates from crustaceans
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/04—Antineoplastic agents specific for metastasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Gastroenterology & Hepatology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Biophysics (AREA)
- Immunology (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Biochemistry (AREA)
- Zoology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Toxicology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Insects & Arthropods (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Tropical Medicine & Parasitology (AREA)
- Oncology (AREA)
- Epidemiology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
La presente invención se encuadra dentro del campo de la farmacología molecular, más específicamente dentro de la inmunoterapia en el desarrollo de péptidos con capacidad antitumoral e inmunomoduladora. El objetivo técnico que se persigue es la identificación de péptidos, cuya estructura permita bloquear su unión al lipopolisacárido y potenciar el efecto anticancerígeno e inmunomodulador. Mostramos nueve péptidos de estructura lineal y secuencia aminoacídica diferente a la secuencia HYRIKPTFRRLKWKKYKGKFW, los cuales no se unen al lipopolisacárido y además incrementan su efecto antitumoral en diversos modelos de tumor, así como su efecto inmunomodulador en células humanas. Estos péptidos o combinaciones de ellos son útiles para el tratamiento del cáncer, así como en sinergismo con las terapias convencionales.
Priority Applications (16)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CU20060047A CU23582A1 (es) | 2006-02-24 | 2006-02-24 | Péptidos con capacidad anti-tumoral e inmunomoduladora |
ARP070100749A AR059608A1 (es) | 2006-02-24 | 2007-02-22 | Peptidos con capacidad anti - tumoral e inmunomoduladora |
KR1020087023166A KR101456205B1 (ko) | 2006-02-24 | 2007-02-23 | 면역조절성 및 항-종양 펩티드 |
ES07711100T ES2358845T3 (es) | 2006-02-24 | 2007-02-23 | Péptidos inmunomodulares y antitumorales. |
JP2008555601A JP5069250B2 (ja) | 2006-02-24 | 2007-02-23 | 免疫調節及び抗腫瘍ペプチド |
BRPI0708148A BRPI0708148B1 (pt) | 2006-02-24 | 2007-02-23 | peptídeos com capacidade antitumoral e imunomoduladora provenientes da região 32-51 da proteína lalf, compostos químicos miméticos aos peptídeos, composição farmacêutica e uso dos peptídeos e compostos químicos |
US12/278,990 US8283324B2 (en) | 2006-02-24 | 2007-02-23 | Immunomodulatory and anti-tumour peptides |
RU2008137968/04A RU2430109C2 (ru) | 2006-02-24 | 2007-02-23 | Иммуномодулирующие и противоопухолевые пептиды |
PCT/CU2007/000006 WO2007095867A1 (es) | 2006-02-24 | 2007-02-23 | Peptidos con capacidad anti-tumoral e inmunomoduladora |
EP07711100A EP1992638B1 (en) | 2006-02-24 | 2007-02-23 | Immunomodulatory and anti-tumour peptides |
CA2638828A CA2638828C (en) | 2006-02-24 | 2007-02-23 | Immunomodulatory and anti-tumor peptides derived from lalf |
AU2007218671A AU2007218671B2 (en) | 2006-02-24 | 2007-02-23 | Immunomodulatory and anti-tumour peptides |
AT07711100T ATE493434T1 (de) | 2006-02-24 | 2007-02-23 | Immunmodulatorische und gegen tumore wirkende peptide |
CN2007800138842A CN101426813B (zh) | 2006-02-24 | 2007-02-23 | 具有免疫调节和抗肿瘤能力的肽 |
MX2008010893A MX2008010893A (es) | 2006-02-24 | 2007-02-23 | Peptidos con capacidad anti-tumoral e inmunomoduladora. |
ZA200807034A ZA200807034B (en) | 2006-02-24 | 2008-08-14 | Immunomodulatory and anti-tumour peptides |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CU20060047A CU23582A1 (es) | 2006-02-24 | 2006-02-24 | Péptidos con capacidad anti-tumoral e inmunomoduladora |
Publications (1)
Publication Number | Publication Date |
---|---|
CU23582A1 true CU23582A1 (es) | 2010-10-30 |
Family
ID=38123823
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CU20060047A CU23582A1 (es) | 2006-02-24 | 2006-02-24 | Péptidos con capacidad anti-tumoral e inmunomoduladora |
Country Status (16)
Country | Link |
---|---|
US (1) | US8283324B2 (es) |
EP (1) | EP1992638B1 (es) |
JP (1) | JP5069250B2 (es) |
KR (1) | KR101456205B1 (es) |
CN (1) | CN101426813B (es) |
AR (1) | AR059608A1 (es) |
AT (1) | ATE493434T1 (es) |
AU (1) | AU2007218671B2 (es) |
BR (1) | BRPI0708148B1 (es) |
CA (1) | CA2638828C (es) |
CU (1) | CU23582A1 (es) |
ES (1) | ES2358845T3 (es) |
MX (1) | MX2008010893A (es) |
RU (1) | RU2430109C2 (es) |
WO (1) | WO2007095867A1 (es) |
ZA (1) | ZA200807034B (es) |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CU23674A1 (es) * | 2007-07-31 | 2011-05-27 | Ct Ingenieria Genetica Biotech | Péptidos penetradores a células fusionados a una biomolécula con acción terapéutica |
EP2108372A1 (en) * | 2008-04-09 | 2009-10-14 | Forschungszentrum Borstel Leibniz-Zentrum für Medizin und Biowissenschaften | Novel antimicrobial peptides |
JP5964233B2 (ja) * | 2009-09-11 | 2016-08-03 | プロイェクト、デ、ビオメディシナ、シーマ、ソシエダッド、リミターダProyecto De Biomedicina Cima, S.L. | Hpvにより惹起される疾患の治療用組成物 |
CU23897B1 (es) * | 2010-05-31 | 2013-05-31 | Ct De Ingeniería Genética Y Biotecnología | Péptido para la terapia del cáncer |
CN103724412A (zh) * | 2013-09-29 | 2014-04-16 | 中国科学院海洋研究所 | 中国明对虾抗脂多糖因子及其制备和应用 |
WO2024006746A1 (en) * | 2022-06-29 | 2024-01-04 | Cdres Pharma Llc | Immunologically active polypeptide |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA2146667A1 (en) * | 1993-08-18 | 1995-02-23 | Adolf Hoess | Lipopolysaccharide-binding and neutralizing peptides |
CU22700A1 (es) * | 1997-09-29 | 2001-07-31 | Ct Ingenieria Genetica Biotech | Formulación farmacéutica anti-viral que contiene un péptido de la proteína factor anti-lps de limulus y su uso |
EP1333847A1 (en) | 2000-11-08 | 2003-08-13 | Lorus Therapeutics Inc. | Combination preparation of a biological response modidier and an anticancer agent and uses thereof |
-
2006
- 2006-02-24 CU CU20060047A patent/CU23582A1/es unknown
-
2007
- 2007-02-22 AR ARP070100749A patent/AR059608A1/es not_active Application Discontinuation
- 2007-02-23 BR BRPI0708148A patent/BRPI0708148B1/pt not_active IP Right Cessation
- 2007-02-23 AT AT07711100T patent/ATE493434T1/de not_active IP Right Cessation
- 2007-02-23 RU RU2008137968/04A patent/RU2430109C2/ru not_active IP Right Cessation
- 2007-02-23 AU AU2007218671A patent/AU2007218671B2/en not_active Ceased
- 2007-02-23 MX MX2008010893A patent/MX2008010893A/es active IP Right Grant
- 2007-02-23 EP EP07711100A patent/EP1992638B1/en active Active
- 2007-02-23 CN CN2007800138842A patent/CN101426813B/zh not_active Expired - Fee Related
- 2007-02-23 US US12/278,990 patent/US8283324B2/en not_active Expired - Fee Related
- 2007-02-23 JP JP2008555601A patent/JP5069250B2/ja not_active Expired - Fee Related
- 2007-02-23 ES ES07711100T patent/ES2358845T3/es active Active
- 2007-02-23 CA CA2638828A patent/CA2638828C/en not_active Expired - Fee Related
- 2007-02-23 KR KR1020087023166A patent/KR101456205B1/ko active IP Right Grant
- 2007-02-23 WO PCT/CU2007/000006 patent/WO2007095867A1/es active Application Filing
-
2008
- 2008-08-14 ZA ZA200807034A patent/ZA200807034B/xx unknown
Also Published As
Publication number | Publication date |
---|---|
RU2008137968A (ru) | 2010-03-27 |
JP5069250B2 (ja) | 2012-11-07 |
JP2009527510A (ja) | 2009-07-30 |
BRPI0708148A2 (pt) | 2011-05-17 |
US8283324B2 (en) | 2012-10-09 |
AU2007218671A1 (en) | 2007-08-30 |
EP1992638B1 (en) | 2010-12-29 |
CN101426813B (zh) | 2012-04-04 |
ATE493434T1 (de) | 2011-01-15 |
MX2008010893A (es) | 2008-09-03 |
KR20080106446A (ko) | 2008-12-05 |
EP1992638A1 (en) | 2008-11-19 |
CN101426813A (zh) | 2009-05-06 |
RU2430109C2 (ru) | 2011-09-27 |
ZA200807034B (en) | 2009-06-24 |
KR101456205B1 (ko) | 2014-10-31 |
ES2358845T3 (es) | 2011-05-16 |
AU2007218671B2 (en) | 2012-02-09 |
CA2638828C (en) | 2014-09-09 |
AR059608A1 (es) | 2008-04-16 |
BRPI0708148B1 (pt) | 2019-01-15 |
CA2638828A1 (en) | 2007-08-30 |
WO2007095867A1 (es) | 2007-08-30 |
US20090221508A1 (en) | 2009-09-03 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CY1123010T1 (el) | Διεγερση γονιδιου τrail με μικρο μοριο απο κανονικα και ογκου κυτταρα ως αντικαρκινικη θεραπεια | |
CY1118714T1 (el) | Υψηλης συγγενειας ανθρωπινα αντισωματα κατα του ανθρωπινου ενεργοποιουμενου απο πρωτεαση υποδοχεα-2 | |
CY1118744T1 (el) | Υποκατεστημενες τρικυκλικες ενωσεις ως αναστολεις fgfr | |
DOP2015000110A (es) | Anticuerpos anti-ceacam5 y usos de estos | |
BR112012013664A2 (pt) | rabdovírus oncolítico | |
CY1121742T1 (el) | Αντισωματα s100a4 και θεραπευτικες χρησεις αυτων | |
ECSP19025350A (es) | Anticuerpos monoclonales optimizados contra el inhibidor de la vía del factor tisular (tfpi) | |
ECSP11011297A (es) | Proteinas ligadoras il-17 | |
EA201992712A3 (ru) | Трициклические гетероциклы как ингибиторы белков бэт | |
CO7180225A2 (es) | Tratamientos de combinación para melanoma que comprenden la administración de cobimetinib y vemurafenib | |
CR20110066A (es) | Anticuerpos monoclonales contra el factor tisular inhibidor de la via | |
CO6710907A2 (es) | Anticuerpos que se unen específicamente a cd33 que son útiles en el tratamiento de trastornos de células mieloides y del síndrome mielodisplásico (msd) | |
EA201290727A1 (ru) | Пирролбензодиазепины и их конъюгаты | |
GB2539350A (en) | Amyloid targeting agents and methods of using the same | |
CL2013000018A1 (es) | Compuestos derivados de indolizina , su procedimiento de preparacion; composicion farmaceutica; y uso en el tratamiento del cancer, entre otros. | |
EA201270722A1 (ru) | Формы рифаксимина и их применение | |
GT200900126A (es) | Novedosos anticuerpos antiproliferacion | |
CR20150604A (es) | Proceso para la preparación de eritrocitos cargados con una o más sustancias de interés farmacéutico y eritrocitos así obtenidos | |
EA201500261A1 (ru) | Конъюгаты антитело-лекарственное средство (adc), которые связываются с белками 158p1d7 | |
EA201591925A1 (ru) | Терапевтические композиции и их применение | |
CU23582A1 (es) | Péptidos con capacidad anti-tumoral e inmunomoduladora | |
AR090352A1 (es) | Anticuerpos frente a los ligandos del receptor b1 de bradicinina | |
CY1123490T1 (el) | Συνθεσεις που προερχονται απο χιτοζανη | |
CR20150140A (es) | Antiandrógenos para el tratamiento del cáncer de prostata resistente a la castración metastásico | |
DOP2012000250A (es) | COMPUESTOS DEL COMPLEJO DE Fe(III) PARA EL TRATAMIENTO Y PROFILAXIS DE LOS SÍNTOMAS DE DEFICIENCIA DE HIERRO Y LAS ANEMIAS POR DEFICIENCIA DE HIERRO |